The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Infection Diagnostic Market Research Report 2024
Synopsis
The global Respiratory Infection Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Infection Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Infection Diagnostic.
Report Scope
The Respiratory Infection Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Infection Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Infection Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ador Diagnostics
BD Diagnostics
Co-Diagnostics
Diagenode Diagnostics
GenePOC Diagnostics
Veradus Labs
Immunexpress
Janssen Diagnostics
Lumos Diagnostics
Oxford Nanopore
Prominex
Roche Molecular Diagnostics
SkylineDx
T2 Biosystems
Segment by Type
Microbiology
PCR
NGS
Immunoassay
Segment by Application
Hospital Lab
Outpatient Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Infection Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Respiratory Infection Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Infection Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Infection Diagnostic.
Report Scope
The Respiratory Infection Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Infection Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Infection Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ador Diagnostics
BD Diagnostics
Co-Diagnostics
Diagenode Diagnostics
GenePOC Diagnostics
Veradus Labs
Immunexpress
Janssen Diagnostics
Lumos Diagnostics
Oxford Nanopore
Prominex
Roche Molecular Diagnostics
SkylineDx
T2 Biosystems
Segment by Type
Microbiology
PCR
NGS
Immunoassay
Segment by Application
Hospital Lab
Outpatient Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Infection Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Infection Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microbiology
1.2.3 PCR
1.2.4 NGS
1.2.5 Immunoassay
1.3 Market by Application
1.3.1 Global Respiratory Infection Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Lab
1.3.3 Outpatient Lab
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Infection Diagnostic Market Perspective (2019-2030)
2.2 Respiratory Infection Diagnostic Growth Trends by Region
2.2.1 Global Respiratory Infection Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Infection Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Infection Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Infection Diagnostic Market Dynamics
2.3.1 Respiratory Infection Diagnostic Industry Trends
2.3.2 Respiratory Infection Diagnostic Market Drivers
2.3.3 Respiratory Infection Diagnostic Market Challenges
2.3.4 Respiratory Infection Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Infection Diagnostic Players by Revenue
3.1.1 Global Top Respiratory Infection Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Respiratory Infection Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Infection Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Infection Diagnostic Revenue
3.4 Global Respiratory Infection Diagnostic Market Concentration Ratio
3.4.1 Global Respiratory Infection Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Infection Diagnostic Revenue in 2023
3.5 Respiratory Infection Diagnostic Key Players Head office and Area Served
3.6 Key Players Respiratory Infection Diagnostic Product Solution and Service
3.7 Date of Enter into Respiratory Infection Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Infection Diagnostic Breakdown Data by Type
4.1 Global Respiratory Infection Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2025-2030)
5 Respiratory Infection Diagnostic Breakdown Data by Application
5.1 Global Respiratory Infection Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Infection Diagnostic Market Size (2019-2030)
6.2 North America Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Infection Diagnostic Market Size by Country (2019-2024)
6.4 North America Respiratory Infection Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Infection Diagnostic Market Size (2019-2030)
7.2 Europe Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Infection Diagnostic Market Size by Country (2019-2024)
7.4 Europe Respiratory Infection Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Infection Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Infection Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Infection Diagnostic Market Size (2019-2030)
9.2 Latin America Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Infection Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Respiratory Infection Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Infection Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Infection Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ador Diagnostics
11.1.1 Ador Diagnostics Company Detail
11.1.2 Ador Diagnostics Business Overview
11.1.3 Ador Diagnostics Respiratory Infection Diagnostic Introduction
11.1.4 Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.1.5 Ador Diagnostics Recent Development
11.2 BD Diagnostics
11.2.1 BD Diagnostics Company Detail
11.2.2 BD Diagnostics Business Overview
11.2.3 BD Diagnostics Respiratory Infection Diagnostic Introduction
11.2.4 BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.2.5 BD Diagnostics Recent Development
11.3 Co-Diagnostics
11.3.1 Co-Diagnostics Company Detail
11.3.2 Co-Diagnostics Business Overview
11.3.3 Co-Diagnostics Respiratory Infection Diagnostic Introduction
11.3.4 Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.3.5 Co-Diagnostics Recent Development
11.4 Diagenode Diagnostics
11.4.1 Diagenode Diagnostics Company Detail
11.4.2 Diagenode Diagnostics Business Overview
11.4.3 Diagenode Diagnostics Respiratory Infection Diagnostic Introduction
11.4.4 Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.4.5 Diagenode Diagnostics Recent Development
11.5 GenePOC Diagnostics
11.5.1 GenePOC Diagnostics Company Detail
11.5.2 GenePOC Diagnostics Business Overview
11.5.3 GenePOC Diagnostics Respiratory Infection Diagnostic Introduction
11.5.4 GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.5.5 GenePOC Diagnostics Recent Development
11.6 Veradus Labs
11.6.1 Veradus Labs Company Detail
11.6.2 Veradus Labs Business Overview
11.6.3 Veradus Labs Respiratory Infection Diagnostic Introduction
11.6.4 Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.6.5 Veradus Labs Recent Development
11.7 Immunexpress
11.7.1 Immunexpress Company Detail
11.7.2 Immunexpress Business Overview
11.7.3 Immunexpress Respiratory Infection Diagnostic Introduction
11.7.4 Immunexpress Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.7.5 Immunexpress Recent Development
11.8 Janssen Diagnostics
11.8.1 Janssen Diagnostics Company Detail
11.8.2 Janssen Diagnostics Business Overview
11.8.3 Janssen Diagnostics Respiratory Infection Diagnostic Introduction
11.8.4 Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.8.5 Janssen Diagnostics Recent Development
11.9 Lumos Diagnostics
11.9.1 Lumos Diagnostics Company Detail
11.9.2 Lumos Diagnostics Business Overview
11.9.3 Lumos Diagnostics Respiratory Infection Diagnostic Introduction
11.9.4 Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.9.5 Lumos Diagnostics Recent Development
11.10 Oxford Nanopore
11.10.1 Oxford Nanopore Company Detail
11.10.2 Oxford Nanopore Business Overview
11.10.3 Oxford Nanopore Respiratory Infection Diagnostic Introduction
11.10.4 Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.10.5 Oxford Nanopore Recent Development
11.11 Prominex
11.11.1 Prominex Company Detail
11.11.2 Prominex Business Overview
11.11.3 Prominex Respiratory Infection Diagnostic Introduction
11.11.4 Prominex Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.11.5 Prominex Recent Development
11.12 Roche Molecular Diagnostics
11.12.1 Roche Molecular Diagnostics Company Detail
11.12.2 Roche Molecular Diagnostics Business Overview
11.12.3 Roche Molecular Diagnostics Respiratory Infection Diagnostic Introduction
11.12.4 Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.12.5 Roche Molecular Diagnostics Recent Development
11.13 SkylineDx
11.13.1 SkylineDx Company Detail
11.13.2 SkylineDx Business Overview
11.13.3 SkylineDx Respiratory Infection Diagnostic Introduction
11.13.4 SkylineDx Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.13.5 SkylineDx Recent Development
11.14 T2 Biosystems
11.14.1 T2 Biosystems Company Detail
11.14.2 T2 Biosystems Business Overview
11.14.3 T2 Biosystems Respiratory Infection Diagnostic Introduction
11.14.4 T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2019-2024)
11.14.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Respiratory Infection Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Microbiology
Table 3. Key Players of PCR
Table 4. Key Players of NGS
Table 5. Key Players of Immunoassay
Table 6. Global Respiratory Infection Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Respiratory Infection Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Respiratory Infection Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Respiratory Infection Diagnostic Market Share by Region (2019-2024)
Table 10. Global Respiratory Infection Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Respiratory Infection Diagnostic Market Share by Region (2025-2030)
Table 12. Respiratory Infection Diagnostic Market Trends
Table 13. Respiratory Infection Diagnostic Market Drivers
Table 14. Respiratory Infection Diagnostic Market Challenges
Table 15. Respiratory Infection Diagnostic Market Restraints
Table 16. Global Respiratory Infection Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Respiratory Infection Diagnostic Market Share by Players (2019-2024)
Table 18. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infection Diagnostic as of 2023)
Table 19. Ranking of Global Top Respiratory Infection Diagnostic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Respiratory Infection Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Infection Diagnostic Product Solution and Service
Table 23. Date of Enter into Respiratory Infection Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Infection Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2019-2024)
Table 27. Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2025-2030)
Table 29. Global Respiratory Infection Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2019-2024)
Table 31. Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2025-2030)
Table 33. North America Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Respiratory Infection Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Respiratory Infection Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Ador Diagnostics Company Detail
Table 49. Ador Diagnostics Business Overview
Table 50. Ador Diagnostics Respiratory Infection Diagnostic Product
Table 51. Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 52. Ador Diagnostics Recent Development
Table 53. BD Diagnostics Company Detail
Table 54. BD Diagnostics Business Overview
Table 55. BD Diagnostics Respiratory Infection Diagnostic Product
Table 56. BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 57. BD Diagnostics Recent Development
Table 58. Co-Diagnostics Company Detail
Table 59. Co-Diagnostics Business Overview
Table 60. Co-Diagnostics Respiratory Infection Diagnostic Product
Table 61. Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 62. Co-Diagnostics Recent Development
Table 63. Diagenode Diagnostics Company Detail
Table 64. Diagenode Diagnostics Business Overview
Table 65. Diagenode Diagnostics Respiratory Infection Diagnostic Product
Table 66. Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 67. Diagenode Diagnostics Recent Development
Table 68. GenePOC Diagnostics Company Detail
Table 69. GenePOC Diagnostics Business Overview
Table 70. GenePOC Diagnostics Respiratory Infection Diagnostic Product
Table 71. GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 72. GenePOC Diagnostics Recent Development
Table 73. Veradus Labs Company Detail
Table 74. Veradus Labs Business Overview
Table 75. Veradus Labs Respiratory Infection Diagnostic Product
Table 76. Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 77. Veradus Labs Recent Development
Table 78. Immunexpress Company Detail
Table 79. Immunexpress Business Overview
Table 80. Immunexpress Respiratory Infection Diagnostic Product
Table 81. Immunexpress Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 82. Immunexpress Recent Development
Table 83. Janssen Diagnostics Company Detail
Table 84. Janssen Diagnostics Business Overview
Table 85. Janssen Diagnostics Respiratory Infection Diagnostic Product
Table 86. Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 87. Janssen Diagnostics Recent Development
Table 88. Lumos Diagnostics Company Detail
Table 89. Lumos Diagnostics Business Overview
Table 90. Lumos Diagnostics Respiratory Infection Diagnostic Product
Table 91. Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 92. Lumos Diagnostics Recent Development
Table 93. Oxford Nanopore Company Detail
Table 94. Oxford Nanopore Business Overview
Table 95. Oxford Nanopore Respiratory Infection Diagnostic Product
Table 96. Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 97. Oxford Nanopore Recent Development
Table 98. Prominex Company Detail
Table 99. Prominex Business Overview
Table 100. Prominex Respiratory Infection Diagnostic Product
Table 101. Prominex Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 102. Prominex Recent Development
Table 103. Roche Molecular Diagnostics Company Detail
Table 104. Roche Molecular Diagnostics Business Overview
Table 105. Roche Molecular Diagnostics Respiratory Infection Diagnostic Product
Table 106. Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 107. Roche Molecular Diagnostics Recent Development
Table 108. SkylineDx Company Detail
Table 109. SkylineDx Business Overview
Table 110. SkylineDx Respiratory Infection Diagnostic Product
Table 111. SkylineDx Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 112. SkylineDx Recent Development
Table 113. T2 Biosystems Company Detail
Table 114. T2 Biosystems Business Overview
Table 115. T2 Biosystems Respiratory Infection Diagnostic Product
Table 116. T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2019-2024) & (US$ Million)
Table 117. T2 Biosystems Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Infection Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Respiratory Infection Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Microbiology Features
Figure 4. PCR Features
Figure 5. NGS Features
Figure 6. Immunoassay Features
Figure 7. Global Respiratory Infection Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Respiratory Infection Diagnostic Market Share by Application: 2023 VS 2030
Figure 9. Hospital Lab Case Studies
Figure 10. Outpatient Lab Case Studies
Figure 11. Respiratory Infection Diagnostic Report Years Considered
Figure 12. Global Respiratory Infection Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Respiratory Infection Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Respiratory Infection Diagnostic Market Share by Region: 2023 VS 2030
Figure 15. Global Respiratory Infection Diagnostic Market Share by Players in 2023
Figure 16. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infection Diagnostic as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Infection Diagnostic Revenue in 2023
Figure 18. North America Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Respiratory Infection Diagnostic Market Share by Country (2019-2030)
Figure 20. United States Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Respiratory Infection Diagnostic Market Share by Country (2019-2030)
Figure 24. Germany Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Respiratory Infection Diagnostic Market Share by Region (2019-2030)
Figure 32. China Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Respiratory Infection Diagnostic Market Share by Country (2019-2030)
Figure 40. Mexico Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Respiratory Infection Diagnostic Market Share by Country (2019-2030)
Figure 44. Turkey Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Respiratory Infection Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Ador Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 47. BD Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 48. Co-Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 49. Diagenode Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 50. GenePOC Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 51. Veradus Labs Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 52. Immunexpress Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 53. Janssen Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 54. Lumos Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 55. Oxford Nanopore Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 56. Prominex Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 57. Roche Molecular Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 58. SkylineDx Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 59. T2 Biosystems Revenue Growth Rate in Respiratory Infection Diagnostic Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
